HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. 

The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.

Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

Between 20% to 24% of all breast cancers diagnosed during a decade-long period were found in women between the ages of 18 to 49, according to research presented at RSNA 2025. 

Will there or won’t there be a federal moratorium on state-level regulation of AI? That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.

Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade. 

A psychiatric patient suffering from hallucinations injured employees at University of Iowa Health Care during a physical altercation. Clinicians restrained and sedated him successfully, but the cocktail of drugs allegedly caused his heart to stop, leading to a permanent brain injury. The case has been settled out of court.

Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.